Assessing depression in youth at clinical high risk for psychosis: A comparison of three measures

Psychiatry Research

Volumn 215, Issue 2, 2014, Pages 323-328

  DeVylder, Jordan E ^a,b   Yang, Lawrence H ^c   Harkavy Friedman, Jill M ^d   Azimov, Neyra ^b   Walder, Deborah J ^e   Corcoran, Cheryl M ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Department of Medicine   (United States)

^d American Foundation for Suicide Prevention   (United States)

^e CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

At risk; Depressive symptoms; Prodrome; Psychometric; Reliability; Schizophrenia; Validity

Indexed keywords

ADOLESCENT; ADULT; COMPARATIVE STUDY; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMAN; MALE; PERSONALITY TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; PSYCHOTIC DISORDERS; REPRODUCIBILITY; SCHIZOPHRENIA; YOUNG ADULT;

ADOLESCENT; ADULT; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84893802124     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.12.002     Document Type: Article

References (62)

1. Addington D., Addington J., Atkinson M. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophrenia Research 1996, 19:205-212.
2. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research 1992, 6:201-208.
3. Addington J., Cornblatt B.A., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. American Journal of Psychiatry 2011, 168:800-805.
4. Addington J., Epstein I., Liu L., French P., Boydell K.M., Zipursky R.B. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophrenia Research 2011, 125:54-61.
5. Addington J., Tran L. Using the brief core schema scales with individuals at clinical high risk of psychosis. Behavioural and Cognitive Psychotherapy 2009, 37:227-231.
6. Ambrosini P.J., Metz C., Bianchi M.D., Rabinovich H., Undie A. Concurrent validity and psychometric properties of the Beck Depression Inventory in outpatient adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1991, 30:51-57.
7. Amminger G.P., Leicester S., Yung A.R., Phillips L.J., Berger G.E., Francey S.M., Yuen H.P., McGorry P.D. Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophrenia Research 2006, 84:67-76.
8. Amminger G.P., Schafer M.R., Papageorgiou K., Klier C.M., Cotton S.M., Harrigan S.M., Mackinnon A., McGorry P.D., Berger G.E. Long-chain ω-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Archives of General Psychiatry 2010, 67:146-154.
9. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
10. Brooks S.J., Kutcher S. Diagnosis and measurement of adolescent depression: a review of commonly utilized instruments. Journal of Child and Adolescent Psychopharmacology 2001, 11:341-376.
11. Brown C., Schulberg H.C., Madonia M.J. Assessing depression in primary care practice with the Beck Depression Inventory and Hamilton Rating Scale for Depression. Psychological Assessment 1995, 7:59-65.
12. Cadenhead K.S., Addington J., Cannon T., Cornblatt B., McGlashan T., Perkins D., Seidman L., Tsuang M., Walker E., Woods S., Heinssen R. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Intervention in Psychiatry 2010, 4:220-226.
13. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 2008, 65:28-37.
14. Chan Y.-F., Leung D.Y.P., Fong D.Y.T., Leung C.-M., Lee A.M. Psychometric evaluation of the Hospital and Depression Scale in a large community sample of adolescents in Hong Kong. Quality of Life Research 2010, 19:865-873.
15. Collins A.A., Remington G., Coulter K., Birkett K. Depression in schizophrenia: a comparison of three measures. Schizophrenia Research 1996, 20:205-209.
16. Corcoran C.M., Kimhy D., Parrilla-Escobar M.A., Cressman V.L., Stanford A.D., Thompson J., Ben David S., Crumbley A., Schobel S., Moore H., Malaspina D. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological Medicine 2011, 41:251-261.
17. Corcoran C.M., Smith C., McLaughlin D., Auther A., Malaspina D., Cornblatt B. HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia. Schizophrenia Research 2012, 135:170-174.
18. Corruble E., Legrand J.M., Zvenigorowski H., Duret C., Guelfi J.D. Concordance between self-report and clinician's assessment of depression. Journal of Psychiatric Research 1999, 33:457-465.
19. Cronbach L.J., Meehl P.E. Construct validity in psychological tests. Psychological Bulletin 1955, 52:281-302.
20. Cuipers P., Li J., Hofmann S.G., Andersson G. Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis. Clinical Psychology Review 2010, 30:768-778.
21. DeVellis R.F. Scale Development: Theory and Applications 2012, Sage Publications, Inc, Washington, D.C. 3rd edition.
22. DeVylder J.E., Ben-David S., Schobel S.A., Kimhy D., Malaspina D., Corcoran C.M. Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis. Psychological Medicine 2013, 43:259-268.
23. DeVylder J.E., Oh A.J., Ben-David S., Azimov N., Harkavy-Friedman J., Corcoran C.M. Obsessive compulsive symptoms in individuals at clinical risk for psychosis: association with depressive symptoms and suicidal ideation. Schizophrenia Research 2012, 140:110-113.
24. Donaldson S.I., Grant-Valone E.J. Understanding self-report bias in organizational behavior research. Journal of Business and Psychology 2002, 17:245-260.
25. Fulford D., Niendam T.A., Floyd E.G., Carter C.S., Mathalon D.H., Vinogradov S., Stuart B.K., Loewy R.L. Symptom dimensions and functional impairment in early psychosis: more to the store than just negative symptoms. Schizophrenia Research 2013, 147:125-131. (in press).
26. Fusar-Poli P., Nelson B., Valmaggia L., Yung A.R., McGuire P.K. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophrenia Bulletin 2013, (in press). 10.1093/schbul/sbs136.
27. Häfner H., an der Heiden W., Maurer K. Evidence for separate diseases? Stages of one disease or different combinations of symptom dimensions?. European Archives of Psychiatry and Clinical Neuroscience 2008, 258:85-96.
28. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960, 23:56-62.
29. Hawkins K.A., McGlashan T.H., Quinland D., Miller T.J., Perkins D.O., Zipursky R.B., Addington J., Woods S.W. Factorial structure of the scale of prodromal symptoms. Schizophrenia Research 2004, 68:339-347.
30. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., Williamson D., Ryan N. Schedule for affective disorders and schizophrenia for school-age children - present and lifetime version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:980-988.
31. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
32. Lako I.M., Bruggeman R., Knegtering H., Wiersma D., Schoevers R.A., Slooff C.J., Taxis K. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. Journal of Affective Disorders 2012, 140:38-47.
33. Lee S.Y., Kim K.R., Park J.Y., Park J.S., Kim B., Kang J.I., Lee E., An S.K., Kwon J.S. Coping strategies and their relationship to psychopathologies in people at ultra high-risk for psychosis and with schizophrenia. Journal of Nervous and Mental Disease 2011, 199:106-110.
34. Marshall C., Addington J., Epstein I., Liu L., Deighton S., Zipursky R.B. Treating young individuals at clinical high risk for psychosis. Early Intervention in Psychiatry 2012, 6:60-68.
35. Mason O., Startup M., Halpin S., Schall U., Conrad A., Carr V. Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophrenia Research 2004, 71:227-237.
36. McGlashan T.H., Zipursky R.B., Perkins D., Addington J., Miller T., Woods S., Hawkins K., Hoffman R., Preda A., Epstein I., Addington D., Lindborg S., Trzaskoma Q., Tohen M., Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry 2006, 163:790-799.
37. McGorry P.D., Yung A.R., Phillips L.J., Yuen H.P., Francey S., Cosgrave E.M., Germano D., Bravin J., McDonal T., Blair A., Adlard S., Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry. 2002, 59(10):921-928.
38. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 2003, 29:703-715.
39. Miller T.J., Zipursky R.B., Perkins D., Addington J., Woods S.W., Hawkins K.A., Hoffman R., Preda A., Epstein I., Addington D., Lindborg S., Marquez E., Tohen M., Breier A., McGlashan T.H. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the "prodromal" sample. Schizophrenia Research 2003, 61:19-30.
40. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 135:382-389.
41. Myles-Worsley M., Weaver S., Blailes F. Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis. Early Intervention in Psychiatry 2007, 1:183-190.
42. Niendam T.A., Berzak J., Cannon T.D., Bearden C.E. Obsessive and compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophrenia Research 2009, 108:170-175.
43. Nolen-Hoeksema S. Sex differences in unipolar depression: evidence and theory. Psychological Bulletin 1987, 101:259-282.
44. Nurnberger J.I., Blehar M.C., Kaufmann A., York-Cooler C., Simpson S.G., Harkavy- Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies: rational, unique features, and training. Archives of General Psychiatry 1994, 51:849-859.
45. Perivoliotis D., Morrison A.P., Grant P.M., French P., Beck A.T. Negative performance beliefs and negative symptoms in individuals at ultra-high risk of psychosis: a preliminary study. Psychopathology 2009, 42:375-379.
46. Phillips L.J., McGorry P.D., Yuen H.P., Ward J., Donovan K., Kelly D., Francey S.M., Yung A.R. Medium term follow-up of a randomized controlled trial of interventions for youth people at ultra high risk of psychosis. Schizophrenia Research 2007, 96:25-33.
47. Pruessner M., Bechard-Evans L., Boekestyn L., Iyer S.N., Pruessner J.C., Malla A.K. Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis. Schizophrenia Research 2013, 146:79-86.
48. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977, 1:385-401.
49. Rietdijk J., Ising H.K., Dragt S., Klaassen R., Nieman D., Wunderink L., Cuipers P., Linszen D., van der Gaag M. Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosis. Psychiatry Research 2013, 209:309-313. (doi: j.psychres.2013.01.012, in press).
50. Ruhrmann S., Schultze-Lutter F., Salokangas R.K.R., Heinimaa M., Linszen D., Dingemans P., Birchwood M., Patterson P., Juckel G., Heinz A., Morrison A., Lewis S., von Reventlow H.G., Klosterkotter J. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European Prediction of Psychosis Study. Archives of General Psychiatry 2010, 67:241-251.
51. Schlosser D.A., Jacobson S., Chen Q., Sugar C.A., Niendam T.A., Li G., Bearden C.E., Cannon T.D. Recovery from an at-risk state: clinical and functional outcomes of putatitively prodromal youth who do not develop psychosis. Schizophrenia Bulletin 2012, 38:1225-1233.
52. Shafer A.B. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. Journal of Clinical Psychology 2006, 62:123-146.
53. Spitzer R., Williams J., Gibbon M., First M. The structured clinical interview for DSM-III-R (SCID): I. History, rationale, and description. Archives of General Psychiatry 1992, 49:624-629.
54. Steer R.A., Beck A.T., Riskind J.H., Brown G. Relationships between the Beck Depression Inventory and the Hamilton Psychiatric Rating Scale for Depression in depressed outpatients. Journal of Psychopathology and Behavioral Assessment 1987, 9:327-339.
55. Thompson J.L., Kelly M., Kimhy D., Harkavy-Friedman J.M., Khan S., Messinger J.W., Schobel S., Goetz R., Malaspina D., Corcoran C. Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis. Schizophrenia Research 2009, 108:176-181.
56. Thompson K.N., Phillips L.J., Komesaroff P., Yuen H.P., Wood S.J., Pantelis C., Velakoulis D., Yung A.R., McGorry P.D. Stress and HPA-axis functioning in young people at ultra high risk for psychosis. Journal of Psychiatric Research 2007, 41:561-569.
57. Walder D.J., Holtzman C.W., Addington J., Cadenhead K., Tsuang M., Cornblatt B., Cannon T.D., McGlashan T.H., Woods S.W., Perkins D.O., Seidman L.J., Heinssen R., Walker E.F. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophrenia Research 2013, 144:43-50.
58. Walker E.F., Walder D.J., Lewine R., Loewy R. Sex differences in the origins and premorbid development of schizophrenia. Psychiatric Illness in Women: Emerging Treatments and Research 2002, 193-214. American Psychiatric Publishing, Inc., Washington, D.C. F. Lewis-Hall, T.S. Williams, J.A. Panetta (Eds.).
59. Woods S.W., Breier A., Zipursky R.B., Perkins D.O., Addington J., Miller T.J., Hawkins K.A., Marquez E., Lindborg S.R., Tohen M., McGlashan T.H. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biological Psychiatry 2003, 54:453-464.
60. Yung A.R., Buckby J.A., Cosgrave E.M., Killackey E.J., Baker K., Cotton S.M., McGorry P.D. Association between psychotic experiences and depression in a clinical sample over 6 months. Schizophrenia Research 2007, 91:246-253.
61. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., McGorry P.D. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophrenia Research 2003, 60:21-32.
62. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research 2004, 67:131-142.